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The Journal of Immunology
Differential IL-17 Production and Mannan Recognition
Contribute to Fungal Pathogenicity and Commensalism
Lisa Rizzetto,*,1 Mirela Kuka,†,1 Carlotta De Filippo,* Alessandra Cambi,‡
Mihai G. Netea,x Luca Beltrame,* Giorgio Napolitani,{ Maria Gabriella Torcia,‖
Ugo D’Oro,† and Duccio Cavalieri*
In this study, we present evidence of differential Th17 responses in humanmonocyte-derived dendritic cells exposed to the pathogenic
Candida albicans or the nonpathogenic Saccharomyces cerevisiae.We use different forms of the microorganisms, cells, hyphae, and
spores, as a toolbox to dissect the role of surface mannan in the fungal immune response. In contrast to the S. cerevisiae yeast cell-
induced Th1 response, dendritic cells stimulated with spores or C. albicans hyphae induce cellular responses shifted toward Th17
differentiation. The differential recognition of specific mannan structures is the master regulator of the discrimination between
harmful and harmless fungi. The switch between spores and yeast is crucial for the commensalism of S. cerevisiae and depends on the
use of a different receptor repertoire. Understanding the role of cell wall recognition during infection might lead to understanding
the boundaries between safety and pathogenicity. The Journal of Immunology, 2010, 184: 4258–4268.
I
ncidence of fungal disease has been rising dramatically in
the past several decades. Successful resolution of pathogenic
fungal disease depends on proper coordination of multiple
components of the host immune response (IR). The innate immune
system is crucial in forming the antifungal response, initiated with
the processing and presentation of Ags by dendritic cells (DCs). The
induction and modulation of DCs depend largely on the sensing of
pathogen-associated molecular patterns (PAMPs) by pattern rec-
ognition receptors (PRRs). Depending on which PRR is engaged,
DCs can release different polarizing factors capable of instructing
the differentiation of the T cell type to better cope with the invading
pathogen (1). The balance between pro- and anti-inflammatory sig-
naling is a prerequisite for successful host–fungal interactions (2).
DC maturation can be induced by stimulation with yeast extract,
suggesting that exposure to yeasts/fungi has been one of the major
forces driving the evolution of the DC-mediated IR.
Althoughmuchprogresshasbeenmade in the studyof the immune
system under challenge from fungal pathogens, there remain nu-
merous aspects of the tolerogenic response in fungi normally under
control thatarepoorlyunderstood.Understanding themechanismsof
cohabitation between humans and nonpathogenic fungi is a pre-
requisite for controlling fungal infections.Of themultitude of fungal
species known, only a few can be considered truly pathogenic in
healthy individuals.
The best-studied fungal microorganism is Saccharomyces cer-
evisiae, a ubiquitous yeast used by the food industry in the pro-
duction of food, wines, and beer (3).
For the past 5 millennia, human societies have coevolved with
the yeast S. cerevisiae, a common colonizer of mucosal surfaces
and part of the normal flora (4). In addition to Candida albicans,
several strains of the S. cerevisiae species have been isolated from
immunocompromised individuals, such as cystic fibrosis or AIDS
patients (5, 6). These findings are not in conflict with the concept
that S. cerevisiae is “generally recognized as safe” but are rather in
agreement with the idea that pathogenicity results from an alter-
ation in the equilibrium between microorganisms and host.
The decision on how to respond to a microorganism, be it
a pathogen or a commensal, is still primarily determined by the
interaction between the microorganism and the cells of the innate
immune system. The importance of cell wall recognition in patho-
genesis has been recently investigated inC. albicans. C-type lectins,
such as Dectin-1, DC-SIGN, and the macrophage mannose receptor
(MR), specifically mediate C. albicans binding and internalization
by DCs (7–9). Moreover, upon C. albicans stimulation, the direct
recognition through the MR is sufficient for inducing a Th17 re-
sponse in PBMCs (10).
The S. cerevisiae cell wall is almost exclusively composed of
glycans. The interaction between the various Saccharomyces cell
wall-associated structures with their counter-receptors, and the
implications to DC function, remain unknown. The only indirect
evidence available indicates that mannan derived from C. albicans
(CA-mannan), but not mannan derived from S. cerevisiae (SC-
*Department of Preclinic and Clinic Pharmacology and ‖Department of Clinic Phys-
iopathology, University of Firenze, Firenze; †Novartis Vaccines, Siena, Italy;
‡Department of Tumor Immunology, Nijmegen Center for Molecular Life Science,
Radboud University Nijmegen Medical Centre; xDepartment of Medicine and Nij-
megen Institute for Infection, Inflammation and Immunity, Radboud University, Nij-
megen, The Netherlands; and {Institute of Research in Biomedicine, Bellinzona,
Switzerland
1L.R. and M.K. contributed equally to this work.
Received for publication September 9, 2009. Accepted for publication February 12,
2010.
This work was supported by funding from the European Community’s Project FP6
DC-THERA EU LSHB-CT-2004-512074 and Project FP7 SYBARIS (Grant Agree-
ment 242220) and by Grant MIUR PRIN 519MIUR060. A.C. was supported by Veni
Grant 916.66.028 from The Netherlands Organization of Scientific Research. The
funders had no role in the study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Address correspondence and reprint requests to Dr. Duccio Cavalieri, University of
Firenze, Viale Pieraccini 6, Firenze 50139, Italy. E-mail address: duccio.cavalieri@
unifi.it
The online version of this article contains supplemental material.
Abbreviations used in this paper: CA-mannan, mannan derived from Candida albi-
cans; DC, dendritic cell; DEG, differentially expressed gene; DPI, diphenyleneiodium
chloride; FC, fold change; IBD, inflammatory bowel disease; IR, immune response;
moDC, monocyte-derived dendritic cell; MR, mannose receptor; PAMP, pathogen-
associated molecular pattern; PRR, pattern recognition receptor; ROS, reactive oxygen
species; sBEF, signed binary enrichment factor; SC, Saccharomyces cell; SC-mannan,
mannan derived from Saccharomyces cerevisiae; YPD, yeast peptone dextrose
Copyright 2010 by TheAmericanAssociation of Immunologists, Inc. 0022-1767/10/$16.00
www.jimmunol.org/cgi/doi/10.4049/jimmunol.0902972
 o
n
 January 17, 2012
w
w
w
.jimmunol.org
D
ow
nloaded from
 
mannan), is able to induce IL-17 production (10), implying that
the different branches of the two structures profoundly influence
the recognition of fungi and the Th response subsequently elicited.
Dimorphic switch in Candida and germination of Aspergillus
spores are two examples of the importance of different life stages in
determining pathogenicity, possibly by exposing different cell wall
components (11, 12). S. cerevisiae cell wall composition radically
changes in different life stages and life forms, such as ascospores.
Ascospores are the outcome of the yeast meiotic cycle and produce
haploid progeny. The ecological significance of sporulation, besides
the generation of variability and interaction with the immune sys-
tem, are still largely unknown. Sporulation is a phenomenon that
involves conformational changes in yeast cells, and the final product
is an ascus (which maintains the characteristic of the residual yeast
cell wall) that encloses four spores (a tetrad). The S. cerevisiae
spores inside the ascus are characterized by a totally different cell
wall composition with respect to cells, whereas the common fungal
PAMPs mainly recognized by DCs, such as b-glucan and mannan,
are covered by chitosan (a21,4-linked glucosamine residues) and
by a layer of indeterminant structure whose major constituent is
cross-linked tyrosine dimers (13). These outermost layers are
unique features of the spore (14).
We used a systems biology approach to understand how different
life stages of the harmless and commensal S. cerevisiae interact with
our immune system, and to unravel the rules of the recognition
game between pathogenic and nonpathogenic microorganisms. In
particular, we investigated the rules of host–fungal cohabitation,
using human monocyte-derived DCs (moDCs) exposed to cells and
spores of the yeast S. cerevisiae as a toolbox to dissect the role of
cell wall components in determining commensalism or pathoge-
nicity traits.
In addition, we discussed the potential of yeast spores to survive
passage through a host and be disseminated in new environments.
Our results bear importantly on the ecological significance of
sporulation and on the central role of fungal cell wall recognition in
discriminating between friends and foes.
Materials and Methods
Reagents
The culture medium used was RPMI 1640 (Life Technologies BRL, Grand
Island, NY) supplemented with glutamine (Sigma-Aldrich, St. Louis, MO),
penicillin and streptomycin (Life Technologies BRL), and 10% heat-in-
activated FCS (Thermo Scientific HyClone Products, Waltham, MA). GM-
CSF and human recombinant IL-4 were from Gentaur (Brussels, Belgium).
The control stimuli used—LPS (1 mg/ml), Curdlan (100 mg/ml), Zymosan
(100 mg/ml), and the receptor agonists laminarin, mannan, chitin, Sulfo-
NHS-LC-biotin, and NBT—were purchased from Sigma-Aldrich. ELISA
kits were obtained from BioSource (Camarillo, CA), except for ELISA for
IL-12p70, which was from R&D Systems (Minneapolis, MN), and IL-17,
from eBioscience (San Diego, CA). Cytochalasin D was from TebuBio
(Milan, Italy). FITC was from Fluka (Castle Hill, New South Wales,
Australia). Mannan and D-mannose were from Sigma-Aldrich. CA-mannan
and glucan were a kind gift from Prof. David Williams and were pre-
viously isolated (15, 16). The following Abs were used: mAb AZN-D1,
AZN-D2 and AZN-D3 anti-DC-SIGN (17), NKI-L19, and anti-b2-
integrins. mAb anti-MMR and mAb DCN46 anti-DC-SIGN were obtained
from BD Pharmingen (San Diego, CA); APC-conjugated mAb anti-
CD45RO from BD Biosciences (San Jose, CA); and Alexa647-conjugated
goat-anti-mouse IgG, and Alexa568 goat-anti-mouse IgG2b from Molec-
ular Probes (Eugene, OR). PKH26 dye was purchased from Sigma-
Aldrich. Human recombinant IL-12p70 was from obtained from Tema
Ricerca (Bologna, Italy), and monoclonal anti-human IL-12 Ab was pur-
chased from R&D Systems.
Yeast culture and preparation
S. cerevisiae diploid strain SK1 (MATa/a HO gal2 cupS can1R BIO) was
cultured in complete medium (2% yeast extract, 1% peptone, 2% glucose,
0.1% glucose [YPD]) for 18 h, then collected, washed twice with sterile
water, and resuspended at 108 cells/ml. To test homogeneous yeast pop-
ulations, pure spore cultures were obtained by using this strain, whose
sporulation efficiency is 100%.
To prepare spores, cells were grown on YPD plates and replicated on
SPOIVmedium (2% potassium acetate, 0.25% yeast extract); a condition of
nitrogen starvation, conducive to sporulation, was assessed by optical mi-
croscopy. Zymolyase (2 mg/ml; Sigma-Aldrich, St. Louis, MO) was used to
digest asci and liberate spores (18). Experiments performed to evaluate
zymolyase sensitivity of asci for this specific strain showed that 15 min of
incubation was the minimum time needed to dissolve the ascus, without
touching the spore cell wall. Zymolyase was inactivated by heat (65˚C for
2 min) and washed away carefully, together with the remainder of the empty
ascus; the spores were then resuspended to a concentration of 108 cells/ml.
The zymolyase treatment did not affect spore cell wall composition, and
spore viability was assessed by plating 100 ml culture (1000 spores/ml) on
YPD in triplicate and obtaining 100% viability. We will use the term spores
and not themore appropriate term ascospores to specifically indicate that the
effects we are observing are due only to the spores, not to the ascus. Ger-
mination of the spores was observed after 24 h of culture in RPMI, and the
exponentially growing cells were starting to divide. Therefore, any analyses
performed at later time points would be affected by this altered state,
whereas no interference should be present until after 24 h. S. cerevisiae
strains BY4741 and BY4741 och1 (kindly provided byNeil Gow, University
of Aberdeen, Aberdeen, Scotland) were cultured in complete medium until
the exponential growth phase and treated as before. C. albicans SC5314
strain was cultured overnight in Saboraud medium at 28˚C and then shifted
to RPMImedium for 18 h at 37˚C to allow hyphal growth. After microscopic
inspection for purity, the hyphal culture was treated as for yeast cells. It
should be noted that in all the experiments performed in this study live
microorganisms were used.
Microorganism survival following uptake by DCs
After 6 h of stimulation, DCs were collected, washed three times with PBS,
treated with zymolyase, and washed twice; cells, lysated with a hypotonic
solution (KCl, 0.05%),were plated onYPD.Survival of yeast cells, spores, or
hyphae after uptakewas reported as the percentage of CFUs after 3 d relative
to the total numberof cells growing in theabsenceofDCexposure. In selected
experiments, diphenyleneiodium chloride (DPI; 10 mM) was added 30 min
before stimulation, and survival of microorganisms was assessed using the
same method. When evaluating survival after exposure, the possible effect
of DMSO and DPI on the stimuli was taken into account.
DC preparation and stimulation
PBMCs were isolated from buffy coat blood sample from healthy donors
from the Transfusion Unit of the Careggi Hospital (Florence, Italy) by
Ficoll-Hypaque density gradient centrifugation (Biochrom, Berlin, Ger-
many). The experimental plan was approved by the local ethical committee,
and informed consent was obtained from all donors. Monocytes were
isolated from low-density PBMCs by magnetic enrichment with anti-CD14
beads (Miltenyi Biotec, Bergish Gladbach, Germany). Cells were cultured
in the presence of GM-CSF (800 U/ml) and recombinant IL-4 (1000 U/ml)
for 6 d to allow DC differentiation (19). DC activation was induced by yeast
in the different life stages. Depending on the experiments, moDCs were
added at different concentrations. Serial dilution of live yeast preparations
was added to the moDCs at different stimuli/DC ratios.
Isolation and priming of T cells
Total CD4+ T cells were obtained from PBMC by negative isolation with
a combination of magnetic sorting (Miltenyi Biotec) and incubated at
a T/DC ratio of 20:1 with autologous moDCs exposed for 12 h with live
spores/yeast. For real-time PCR, cells were collected after 24, 48, and 72 h
or 5 d of coculture. Supernatants were collected after 5 d of coculture for
cytokine detection.
Cytokine production
After the times indicated, supernatantswere collected, andcytokinedetection
was performed. MesoScale Assay 7-spot (Meso Scale Discovery, Gai-
thersburg, MD) was used for detection of IL-1b, IL-8, IL-6, TNF-a, IL-10,
and IL-12p70, according to the manufacturer’s instructions. Alternatively,
ELISA assay was performed according to the manufacturer’s instructions.
In the blocking experiment, after 2 h of exposure with the inhibitor, su-
pernatants were collected following 8 h or 24 h or 5 d of incubation.
Quantitative real time PCR
Total RNAwas extracted with the RNeasyMini Kit (Qiagen, Valencia, CA).
Random hexamer and reverse transcriptase kit (SuperScript II; Invitrogen,
The Journal of Immunology 4259
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Carlsbad, CA) were used for cDNA synthesis. Quantitative real-time PCR
for FOXP3 gene expression was performed using primer pairs and SYBR
Green PCR Mater Mix (Applied Biosystems, Foster City, CA). Transcripts
for IL-6, IL-17A, and IFN-g were quantified with Applied Biosystems
predesigned TaqMan Gene Expression Assays and reagents according to
the manufacturer’s instructions. Quantification of the PCR signals was
performed by comparing the cycle threshold value of the gene of interest
with the cycle threshold value of the reference gene GAPDH. Values are
expressed as fold increase (fold change [FC]) of mRNA relative to that in
unstimulated cells.
IL-12p70 inhibition by cytochalasin D
DCs were exposed to cytochalasin D (10 mg/ml) for 30 min at 4˚C. After
washing with cold PBS, DCs were stimulated with live yeast or spores at
a stimuli/DC ratio of 4:1 for 24 h. IL-12p70 production was assessed by
ELISA.
IL-12p70 blocking assay
DCs were stimulated for 8 h with live spores of S. cerevisiae andC. albicans
hyphae at a stimuli/DC ratio of 4:1 in the presence of different concen-
trations of human rIL-12p70 (0, 1, 10, and 100 ng/ml). Alternatively,
DCs were preincubated with different concentrations (0, 0.1, 1, 10, and
100 mg/ml) of a monoclonal anti-human IL-12 Ab for 2 h, then stimulated
for 8 h with live S. cerevisiae cells in a stimuli/DC ratio of 4:1. IFN-g and
IL-17 productions were assessed in T cells 5-d culture supernatants.
Phagocytosis assay
Live yeasts/spores were biotinylated using 10 mg/ml sulfo-NHS-LC-biotin
in 50 mM NaHCO3, pH 8.5, for 2 h at 4˚C. The remaining reactive biotin
molecules were inactivated by incubation in 100 mM Tris-HCl, pH 8.0, for
40 min at 4˚C. DCs were then treated with biotinylated spores/yeasts. After
1 h, cells were permeabilized and labeled with aHLA-DR-FITC. After
zymolyase treatment, intracellular yeasts/spores were detected using APC-
labeled streptavidin and analyzed by flow cytometry.
NBT assay
To determine reactive oxygen species (ROS) production, we used the
modified version by Choi et al. (20) of the microscopic NBT assay.
Competition assay
DCs were exposed to laminarin (500 mg/ml), mannan (500 mg/ml), and
chitin (500 mg/ml) for 30 min at 37˚C. After washing with PBS, DCs were
exposed to live yeast cells or spores at a concentration of 4:1 for 6 h.
Inhibition ability of TNF-a production was assessed by ELISA.
S. cerevisiae binding assay
Labeling of live S. cerevisiae cells or spores was performed as previously
described (21). The binding of DCs or CHO-DC-SIGN to S. cerevisiae yeast
cells or spores was measured by flow cytometry using the FACS Calibur
(BD Biosciences) and performed as already described. To test the effects of
various reagents on ligand binding, the following concentrations were used:
different carbohydrates (150 mg/ml); mannose (100 mM); isotype control,
AZN-D1, AZN-D2, AZN-D3 anti-DC-SIGN, anti-MMR, and anti-b2-
integrin (30 mg/ml); and EGTA and EDTA (2 mM). Incubation was per-
formed in 20 mM Tris, pH 8.0, 150 mM NaCl, 1 mM CaCl2, 2 mMMgCl2,
and 1%BSA. FITC-labeled yeast cells or spores were added in a stimuli:DC
ratio of 10:1. After 30 min of incubation at 37˚C, cell–S. cerevisiae con-
jugates were analyzed by flow cytometry. DCs were labeled with anti-
CD45-APC and CHO-DC-SIGN with PKH26 to discriminate cells binding
FITC-labeled yeast/spore particles from yeast/spore aggregates.
Internalization assay
Immature DCs were allowed to adhere onto fibronectin and subsequently
incubatedwithFITC-labeled liveyeast or spores for5, 15, and30minat 37˚C.
At the end of the incubation period, the samples were fixed in 4% para-
formaldehyde, permeabilized in methanol, and labeled for DC-SIGN and/or
MMR, using specific mAb and isotype-specific fluorescent secondary Abs.
Samples were analyzed using a Zeiss (Oberkochen, Germany) LSM 510
confocal microscope.
In vivo survival assay
The experimental protocol was designed in conformity with the recom-
mendations of the European Economic Community (86/609/CEE) for the
care and the use of laboratory animals, was in agreement with the Good
Laboratory Practices, and was approved by the Animal Care Committee of
the University of Florence (Florence, Italy). One-month-old rats were fed for
4 wk on a daily basis with water containing live 1 3 107 SK1 yeast cell or
spores (n = 3) or cells (n = 3). A group of rats (n = 3) was fed with water
containing any stimuli as control. From 1 to 4 wk, fecal samples were
collected and after serial dilution were plated on YPD medium with
chloramphenicol (100 ng/ml) to allow growth of CFU. After 3 d, CFU were
counted. Survival of spores referred to the number of CFU grown after 3 d.
DC transcriptional analysis
A total of 23 106 DCs were cultivated with live cells of S. cerevisiae cells,
spores, hyphae of C. albicans, or without any stimuli in a ratio of 4:1. After
4 h, the time after which the spores are not germinating, cells were col-
lected. RNA preparation, labeling, hybridization on a HT12 array (Illu-
mina, San Diego, CA), and scanning were performed according to the
Illumina reference protocols.
Array preprocessing
Bead-summary data saved from Illumina BeadStudio was preprocessed in
several steps. First, the background signal was assessed and corrected using
the intensity signal from the control probes present on the array; then
quantile normalization was performed. In addition to background correc-
tion, Illumina probe identifiers were converted to nucleotide universal
IDentifiers (22) specific for the nucleotide sequence of each probe. The
computation was performed using the lumi package (23), written in the R
programming language.
Data have been submitted to the Array Express repository (experiment ID
E-MTAB-135, www.ebi.ac.uk/microarray-as/ae/).
Differential expression and annotation
Differential expression analysis was carried out using the Rank Product
algorithm (24), taking into account the differences between donors. The
p values estimating differential expression were corrected for multiple
testing (false discovery rate), and genes with a corrected p value # 0.05
were selected. Gene differential expressions of the stimulated cells with
respect to the unstimulated control were expressed as FC in natural scale.
A FC , 0.5 means downregulation. A FC . 2 means upregulation. To
compare the different stimulation conditions, a ratio between the FC of the
interested gene was done.
Pathway analysis
Pathway analysis was performed with Eu.Gene (25), over a set of 80
pathways selected by the DC-THERA consortium. Prior to the analysis,
microarray raw data were transformed into absolute-scale values and
processed following the procedure outlined by Beltrame et al. (26): First,
ratios between each treated condition and the unstimulated controls were
calculated. Then, in an effort to reduce interdonor variability, the mean of
the ratios for all replicates in a specific condition was calculated. The
resulting ratios were used to perform pathway analysis using Fisher’s exact
test, and the resulting signed p values were transformed into signed binary
enrichment factors (sBEFs). sBEFs were clustered, using Euclidean dis-
tance as metric, bootstrapping the data over 1000 iterations. This com-
putation was carried out with the TIGR Multiexperiment Viewer 4.4.
Statistics
A Student t test was used to evaluate the statistical significance of the
results, by comparison between spores and yeast or between control and
blocking conditions. Results were classified as nonsignificant (p . 0.05),
significant (p , 0.05), and highly significant (p , 0.01).
Results
Differential IR to pathogenic and harmless fungi
To understand the rule of proper recognition, we investigated the IR
to different life stages of S. cerevisiae, a cell form and spores, and
hyphae of C. albicans. Through transcriptional analysis on moDCs
exposed to these fungi, we obtained lists of differentially expressed
genes (DEGs) for each stimulation, compared with unstimulated
controls. A total of 1179 genes were commonly activated in the
three stimulation conditions (Fig. 1A, Supplemental Table I). Gene
clustering showed an upregulation of a wide range of DEGs in-
volved in IRs and inflammation, such as genes coding for cytokines,
chemokines, and immune receptors (Supplemental Fig. 1). The
upregulation of genes coding for the receptors, TLR-2 and TLR-1
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and Dectin-1, the adaptor proteins Syk and Card9, and cos-
timulatory molecules outlined a common maturation process be-
tween S. cerevisiae and C. albicans stimulation (Fig. 1B). Despite
the upregulation of TLR, the C-type lectin Dectin-1 downregulated
upon engagement. In contrast to what occurred upon S. cerevisiae
yeast cell/spore challenge, C. albicans hyphae did not induce
downregulation of Dectin-1 (CLEC7A), presumably indicating lack
of recognition by Dectin-1. The downregulation of the gene coding
for the adaptor Syk suggests a possible engagement of Dectin-2 in
hyphal response (27).
Inaddition to thecommonlyactivatedgenes, asetof174geneswas
differentially expressed only after S. cerevisiae cell stimulation,
whereas 444 and 507 genes were uniquely differentially expressed
after C. albicans and S. cerevisiae spore stimulation, respectively.
The comparative analysis ofSaccharomyces cell-stimulatedmoDCs
and Candida hyphae-stimulated moDCs showed a marked expres-
sion of several proinflammatory mediators and factors involved in
the DC maturation process, including the activation of IL12A (Fig.
1C). The strong induction of proinflammatory and Th1 polarizing
cytokine genes induced by S. cerevisiae cells was counterbalanced
by an increased expression of factors involved in immune modu-
lation that limit DC activation as well as T cell effector function,
such as IL-10, KINU, and IDO (28–30). Genes for the Th17 po-
larizing factors IL-1b and IL-6 were also found to be more ex-
pressed in Candida-stimulated DCs (Fig. 1D), showing that
different fungi induce a peculiar maturation program of stimulated
DCs. Furthermore, S. cerevisiae cells activated a stronger induction
of IFNB1 [recently associated with an internalized TLR2 recogni-
tion (31)] and of IFN-dependent genes and chemokines involved in
Th1 responses (32) and in the mechanism of intracellular protection
from pathogen invasion, whereas Candida promotes a preferential
expression of CCL20, which has been associated with Th17 re-
sponses (33–35) that are protective against extracellular pathogens.
The comparison of S. cerevisiae cell and spore stimulation
showed a strong induction of proinflammatory and Th1 polarizing
cytokine gene activation, counterbalanced by an increased ex-
pression of factors involved in immune modulation (Fig. 1E).
Conversely, genes for the Th17 polarizing factors IL-1b and IL-6
were found more expressed in spore-stimulated DCs (Fig. 1F), in
a Candida-like manner, suggesting that different life stages of
S. cerevisiae can induce a different maturation program of DCs.
To investigate the regulation of pathways and cellular networks in
our samples, we performed a pathway analysis and clustered the
results as sBEFs (26) (Fig. 2). We observed a general activation of
the IR pathway in all conditions. In particular, we observed the
activation of pathways, such as the TLR signaling pathway, JAK-
STAT signaling, COX reaction, and cytokine–cytokine receptor
interaction. The TCR signaling pathway and apoptotic pathway
were also significantly activated in all three stimulation conditions.
Furthermore, the clustering analysis separated C. albicans and
S. cerevisiae into two distinct groups. This finding suggested
a different DC response to pathogenic and nonpathogenic fungi.
The comparison among S. cerevisiae cells, spores, C. albicans
hyphae, and A. fumigatus (data obtained from a public repository)
strengthened this observation (Supplemental Fig. 2). These findings
suggested that S. cerevisiae spores are teleologically similar to
C. albicans hyphae in terms of ability to induce a DC response,
possibly related to the different cell wall component disposition
among S. cerevisiae cells and spores.
Spores circumvent the DC activation process
To assess the cytokine response of moDCs to S. cerevisiae treat-
ment, we exposed moDCs to yeast or spores for 24 h. In agree-
ment with the microarray data, yeast cells, compared with spores,
promoted an increased production of IL-12p70 and IL-10 (Fig.
3A). To understand if this behavior could be related to pathogenic
fungi, DC stimulation with C. albicans hyphae was also per-
formed in parallel.
The absence of IL-12p70 induction upon spore stimulation was
observed even after massive or prolonged stimulation (Fig. 3B, 3C).
To rule out that zymolyase treatment could interfere in DCs
recognition of spores, crucial experiments, such as IL-12p70
production by DCs, were performed in parallel by DC stimulation
with liberated spores, liberated spores treated with zymolyase for 5
min more, and untreated asci. Upon asci stimulation, the level of
IL-12p70 was comparable to that induced upon spore challenge
(Supplemental Fig. 3). This demonstrated that the 15-min zymo-
lyase treatment does not affect the spore wall structure in a way that
will interfere with the IR.
IL-12p70 production in the presence of C. albicans depends on
internalization of the pathogen by DCs (36). By blocking in-
ternalization of S. cerevisiae yeasts and spores, using cytochalasin
D, an inhibitor of actin polymerization, we showed that IL-12p70
synthesis induced by the yeast form was strongly suppressed (Fig.
4A), suggesting that cytokine production was dependent upon S.
FIGURE 1. IR genes activated by Saccharomyces cerevisiae cells or
spores and C. albicans hyphae in moDCs. Transcriptional analysis was
performed on moDCs after 4 h of stimulation with S. cerevisiae cells and
spores, with C. albicans hyphae, or without any stimuli. A, Venn diagram
of DEGs. The full cluster is available as Supplemental Fig. 1. B, Selection
of IR differentially regulated genes (p # 0.05) expressed upon S. cer-
evisiae or C. albicans. The differential expression is expressed as FC. C,
IR differentially regulated genes (p # 0.05) more expressed in SC cell-
stimulated DCs compared with Candida-stimulated DCs. D, IR differen-
tially regulated genes (p # 0.05) more expressed in Candida-stimulated
DCs compared with SC-stimulated DCs. E, IR differentially regulated
genes (p # 0.05) more expressed in SC-stimulated DCs compared with
Saccharomyces spore-stimulated DCs. F, IR differentially regulated genes
(p # 0.05) more expressed in Saccharomyces spore-stimulated DCs
compared with SC-stimulated DCs. SC, Saccharomyces cell.
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cerevisiae internalization. The lack of IL-12p70 production by
spore-stimulated DCs could be related to a lower phagocytosis
rate of spores; thus we evaluated the ability of moDCs to in-
ternalize spores. We found that spores, as well as yeast cells,
similarly interacted with DCs and that spores were equally in-
ternalized, as observed after elimination of surface-bound stimuli
by zymolyase treatment (Fig. 4B, 4C).
This finding indicates that spores and yeast cells are equally
taken up by DCs.
We next investigated the degradation process of S. cerevisiae
yeast cells and spores and C. albicans hyphae in the phagosome by
evaluating survival following their uptake by moDCs. We cultured
moDCs in the presence of S. cerevisiae yeast cells or spores and
C. albicans, then lysated the DCs and plated them on yeast growth
medium. As shown in Fig. 4D, significantly more colonies were
obtained from internalized spores or C. albicans, compared with
S. cerevisiae yeasts, after 6 h of exposure. We therefore measured
ROS production by DCs cultured with yeast or spores for 8, 24, and
48 h (Fig. 4E). The reduced production of ROS in the presence of
spores, together with the intrinsic resistance of spore wall structure
to acidic pH, might account for the increased intracellular survival
ability of spores, compared with yeast cells.
ROS production is one of the parameters that most likely reflect
differences in intracellular killing: Previous studies demonstrated
the important role of NADPH oxidase-induced ROS in DC killing
of C. albicans.
To link production of ROS and survival of spores upon in-
ternalization, we performed survival experiments in the presence of
DPI, an inhibitor of flavoproteins, including NADPH oxidase,
which is known to abrogate ROS production by DCs in response to
PMA (37). DPI treatment (10 mM) abrogated the ability of DCs to
kill S. cerevisiae cells without affecting spore survival (Fig. 4F).
These results indicate that ROS produced by NADPH oxidase play
an important role in DC fungicidal activity and suggest that the
increased survival of spores could be related to an escape mech-
anism from oxidative damage, as reported for C. albicans (38).
We can speculate that the lack of IL-12p70 production and the
reduced production of ROS might be mechanisms by which spores
circumvent the DC activation process.
DCs stimulated by diverse forms of S. cerevisiae prime
a different Th response
Whether Th1 or Th17 responses arise depends on the balance be-
tween the Th1 polarizing factor IL-12p70 and the Th17 polarizing
factors (IL-1, IL-6, and IL-23 in humans), with IL-12p70 being
dominant over Th17 polarizing factors (39). The evidence that
moDCs released IL-12p70 in the presence of yeast cells and almost
no IL-12p70 in the presence of spores prompted us to ask whether
moDCs, which were matured in the presence of these two forms of
S. cerevisiae, differed in their capacity to promote Th1 and Th17
responses. Quantitative real-time PCR assays were performed to
assess the expression over time of IL-6 and IL-17A genes, encoding
for cytokines involved in Th17 polarization, and the IFNG gene,
encoding for the main cytokine produced by Th1 cells on CD4+
T cells stimulated with spore or yeast-stimulated DCs (Fig. 5). The
analysis showed an increase of IL-17A mRNA and of IL-6 mRNA
in T cells exposed to spore-stimulated and C. albicans-stimulated
DCs, compared with unstimulated DCs just after 24 h of coculture.
By contrast, yeast-stimulated DCs did not induce IL-17A gene ac-
tivation and only slightly increased IL-6 gene activation (Fig. 5A).
The INFG gene was activated by all the stimuli. The expression of
the FOXP3 gene was found to be increased in T cells after 5 d of
coculture with yeast-stimulated DCs only (Fig. 5B), suggesting that
yeast cells might induce the differentiation of a regulatory T cell
population, as also supported by microarray data (Fig. 1C, Sup-
plemental Table I). In coculture experiments with autologous CD4+
T lymphocytes, we used C. albicans hyphae stimulation as the
control stimulus for IL-17 induction. As expected, IL-12–pro-
ducing, yeast-matured DCs promoted a pure Th1 response, in-
ducing the release of IFN-g only (Fig. 5C). In contrast, spore-
stimulated DCs, such as the pathogenic fungusC. albicans, induced
the release of a substantial amount of IL-17 together with IFN-g,
consistent with the presence of a Th17 response (Fig. 5C). Thus, the
low levels of IL-12p70 induced by spore stimulation were sufficient
to induce a Th1 response, but they could also allow the effect of
Th17 polarizing factors on IL-17 production by CD4+ T cells. To
assess the importance of IL-12p70 in the balance of Th1/Th17 re-
sponses, we cultured DCs with spores or C. albicans hyphae in the
presence of human rIL-12p70. The added IL-12p70 during DC
stimulation by spores rescued the ability of DCs to polarize a pure
Th1 response in a dose dependent fashion, as well as antagonized
IL-17 induction by C. albicans (Fig. 6A), indicating that high
amounts of IL-12 can indeed counteract the effect of the Th17
FIGURE 2. Spores induce a response closed to C. albicans. Clustering
of sBEFs using Euclidean distance that uses support trees on DC stimu-
lated with S. cerevisiae cells and spores and with C. albicans. Colored
spots indicate significant (p = 0.05) upregulation (red) or downregulation
(green). The colors of the dendrogram indicate the percentages of the tree
support (significance), from 50% (pink) to 100% (black).
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polarizing factor. To address this observation in yeast-stimulated
DCs, we used an Ab against IL-12 to block the activity of the cy-
tokine. The block of IL-12 activity favored Th17 cell activation
(Fig. 6B). This finding demonstrates the important role exercised by
IL-12 in balancing the fungal IR.
MR and DC-SIGN are differently involved in S. cerevisiae
recognition by DCs
To identify which receptors are involved in the differential recog-
nition of S. cerevisiae spores, we performed experiments with
competitive ligands of the structures most commonly involved in
fungal recognition: laminarin for dectin-1, mannan for MR, and
chitin for chitin receptors (40). Blocking each of these receptors
resulted in an inhibition of TNF-a production in DCs stimulated by
yeast cells (Fig. 7A). On the contrary, none of the three competitor
ligands was able to inhibit TNF-a release in spore-stimulated DCs,
suggesting that the molecular pathways involved in spore recog-
nition could be different from those commonly implicated in yeast–
DC interaction.
Human DCs are able to bind C. albicans through MR (8) and
DC-SIGN (9). To assess whether these receptors could contribute
to the different recognition of yeast cells or spores by DCs, we
used the transfectant (CHO) cell line stably expressing DC-SIGN
to investigate the ability of S. cerevisiae cells or spores to bind
DC-SIGN in the absence of any other known fungal receptors.
Binding studies demonstrated that DC-SIGN clearly mediates
adhesion to both yeast cells and spores (Fig. 7B). Blocking-Abs
against DC-SIGN significantly inhibited binding of S. cerevisiae by
CHO-DC-SIGN. Furthermore, the calcium chelator EGTA abro-
gated binding. This Ca2+ dependence confirms that the C-type lectin
domain of DC-SIGN mediates binding to yeast cells and spores. To
gain further insight into the specificity of DC-SIGN recognition, we
analyzed several purified fungal cell wall components for their ca-
pacity to inhibit the interaction betweenDC-SIGNand S. cerevisiae.
CA-mannan was the only carbohydrate that inhibited DC-SIGN
binding to S. cerevisiae. SC-mannan was not able to inhibit binding
of spores, as previously observed for C. albicans (9). To determine
the receptor repertoire involved in the interactions betweenDCs and
S. cerevisiae, we performed similar experiments using moDCs and
blocking MR and DC-SIGN either with purified fungal cell wall
glycans (Fig. 7C) or with Abs (Fig. 7D). Blocking of b2-integrin
receptors was used as negative control. Again, blocking-Abs against
DC-SIGN significantly inhibited binding of spores and yeast cells
by DCs, suggesting that DC-SIGN plays an important role in S.
cerevisiae recognition. Interestingly, blocking of MR, using Ab or
mannose, affected only the DC ability to bind yeast cells, whereas it
had no effect on the binding to spores. To assess whether the dif-
ferent recognition of spores and yeast cells by DCs influences the
internalization, we performed a phagocytosis assay, specifically
labeling MR and DC-SIGN. By confocal microscopy, the double
labeling showed that, after yeast cell stimulation,MRandDC-SIGN
colocalized in the same phagocytic vesicle (Fig. 7E, Supplemental
Fig. 4). This observation indicates that yeast cells were internalized
by DCs in vesicles containing both MR and DC-SIGN as well as
mutually exclusive vesicles, as previously reported for C. albicans
internalization (41). In contrast, spores were internalized by DCs in
vesicles containing DC-SIGN only as shown by the lack of coloc-
alization of the two receptors (Fig. 7E, Supplemental Fig. 5). These
results clearly demonstrate that DCs use a different PRR repertoire
to recognize different life stages of the same microorganism.
FIGURE 3. Cytokine profile of spore-stimulated and yeast-stimulated DCs. A, DCs were exposed for 24 h to S. cerevisiae spores or yeast cells, to
C. albicans, or without any stimuli in a concentration (expressed as stimuli/DC ratio) of 10:1. Cytokine production in supernatants was evaluated by Meso
Scale or ELISA assay. Spore-matured DCs induced more production of IL-6 and IL-1b and failed to induce IL-12p70 production, compared with yeast-
stimulated DCs, which induced IL-10 production. B, DCs were exposed at different concentrations of yeast cells (n) or spores (s), and IL-12p70 was
evaluated after 24 h in culture supernatants. C, DCs were exposed to spores and yeast cells at 10:1 ratio, and IL-12p70 was evaluated after 2 (gray bars),
8 (white bars), and 30 h (black bars) of stimulation. Data are representative of mean 6 SD (A, n = 3; B, n = 3; C, n = 4). Statistical comparisons between
samples are represented as horizontal bars. pp , 0.05; ppp , 0.01.
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Specific role of mannan structures for interaction of host cells
with S. cerevisiae
It was recently demonstrated that the MR is the main pathway
through which C. albicans induces a Th17 response upon PBMC
stimulation. Because SC-mannan itself cannot induce IL-17 pro-
duction, despite interacting with MR (10), and spores lack exposed
mannan, we further investigated the specific role of this branched
carbohydrate in stimulating the innate S. cerevisiae IR. SC-mannan
itself stimulated IL-12p70 production by DCs; furthermore, the
amount of cytokine produced was sufficient to inhibit IL-17 pro-
duction by T cells induced by spores (Fig. 8A). This finding sug-
gests that the lack of SC-mannan in spores may be responsible for
low IL-12 production.
From previous reports, it is known that Candida och1 mutant,
defective in the mannosylation process, failed to interact with DCs,
supporting the important role played by N-linked mannan in the
binding of C. albicans to DCs (9). In contrast, in S. cerevisiae, the
OCH1 gene is required not only for proper mannosylation but also
for masking the b-glucan and immune recognition by the Dectin-1
pathway (42) involved in Th17 priming (33). This prompted us to
further investigate the effects of the absence of exposed mannan in
FIGURE 4. Internalization, survival rate of yeast or spore forms of
S. cerevisiae and induction of ROS production by DCs. A, DCs pretreated
or not with cytochalasin D (10 mg/ml) were stimulated for 24 h with yeast
cells or spores. IL-12p70 was measured by ELISA. Confocal fluorescent
microscopy (B) and flow cytometry (C) of DCs exposed to yeast and spores
at stimuli/DC ratio of 4:1. DCs were treated with zymolyase to detect
intracellular yeasts/spores only, labeled with aHLA-DR-FITC, and bio-
tinylated yeasts/spores were labeled with streptavidin-APC (SA-APC). D,
Survival of S. cerevisiae spores and yeast cells and C. albicans hyphae
after culturing with DCs. Stimuli were cultured alone (black bars) or with
DCs (4:1 ratio). After 6 h of exposure, DCs were treated (gray bars) or not
(white bars) with zymolyase and lysated. Data are expressed as percentage
of CFU of yeast growing. E, ROS production by DCs in response to
stimuli. DCs were stimulated with yeast cells (gray bars), spores (black
bars), or without any stimuli (white bars) at a 4:1 ratio. NBT assay was
performed after the time indicated. F, NADPH oxidase-induced ROS ac-
count for the killing of S. cerevisiae cells. Stimuli were cultured alone or
with DCs (4:1 ratio) in the presence of absence of DPI (10 mM). After 6 h
of exposure, DCs were treated with zymolyase (white bars), and lysated.
DPI did not influence viability of stimuli. Data are expressed as percentage
of CFU of yeast growing. Data are representative of three separate ex-
periments (A–F, mean 6 AD). Statistical comparisons between samples
are represented as horizontal bars. pp , 0.05; ppp , 0.01.
FIGURE 5. Effect of spore-stimulated DCs or yeast-stimulated DCs on
CD4+ effector T cell differentiation. CD4+ cells were cocultured in a ratio
of 20:1 with autologous moDCs, which matured for 12 h with S. cerevisiae
or C. albicans. A, IL6, IL17A, and IFNg gene expression assessed by real-
time PCR in CD4+ T cells exposed to spores (s) or yeast cell (n) for 24,
48, and 72 h. B, FOXP3 gene expression assessed by real-time PCR in
CD4+ T cells exposed to spores or yeast cell for 5 d. C, IL-17 and IFN-g
measurement in 5-d culture supernatants of CD4+ T cells produced in
response to yeast- and spore-stimulated DCs assessed by ELISA. Data are
representative of three (A, B, mean 6 SD) and seven (C, mean 6 SD)
separate experiments. Statistical comparisons between samples are repre-
sented as horizontal bars. pp , 0.05; ppp , 0.01.
FIGURE 6. IL-12p70 drives the balancing between Th1 and Th17 re-
sponse. A, Human rIL-12p70 rescues Th1 polarization upon S. cerevisiae
spore and C. albicans hyphae stimulation in a dose-dependent fashion. DCs
were treated with spores or C. albicans (4:1, stimuli/DC ratio) for 8 h in the
presence of human rIL12-p70 at different concentrations, and the ability of
DCs to polarize a Th1 or a Th17 response was assessed by IFN-g and IL-17
measurement, respectively, by ELISA in 5-d culture supernatants of CD4+
T cells.B, Blocking IL-12p70 activity, using an Ab specific for IL-12, results
in a loss of IFN-g induction and promotes IL-17 production in 5-d culture
supernatants of CD4+ T cells in response to yeast- stimulated DCs (4:1,
stimuli/DC ratio). Statistical comparisons between samples are represented
as horizontal bars. pp , 0.05; ppp , 0.01.
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Th17 induction by S. cerevisiae spores. Cytokine production by
DCs and by CD4+ T cells stimulated with spore-, yeast-, or C. al-
bicans hyphae-matured DCs was measured. Stimulation with
S. cerevisiae och1 mutant yeast cells polarized a Th1/Th17 pop-
ulation toward the type of responses induced by spores (Fig. 8B).
Stimulation with C. albicans hyphae polarized a Th17 response, as
previously demonstrated (10). These data demonstrate that the
presence of exposed mannan on the cell wall influences the IR
mounted by the DCs to properly respond and tolerate S. cerevisiae
yeast cells, in a different fashion from what occurs with C. albicans
hyphae. We demonstrated that spores are recognized by DC-SIGN,
not by MR, and we know that SC-mannan is a ligand for DC-SIGN
as well as MR. To understand the relative contribution of these two
receptors in S. cerevisiae Th response, we exposed DCs to blocking
Abs before exposure to spores and yeast cells. The blocking of MR
induced the decrease in IL-12p70 production and an increase of IL-
17 induction upon yeast cell stimulation, whereas blocking of DC-
SIGN showed a slight effect on IL-17 production (Fig. 8C). Thus,
we show that in contrast to C. albicans hyphae stimulation,
S. cerevisiae cell interaction with DCs, exerted by mannan, favors
the IL-12/IFN-g axis, whereas the absence of exposed mannan in
spores induces a Th17 response.
Discussion
Host–fungal interactions have so far been studied only for patho-
genic fungi, such as C. albicans; it is not known what determines
the commensalism of harmless fungi. In particular, the rules gov-
erning the interaction of S. cerevisiae and our immune system are
almost completely unknown. This is the first report that addresses
the mechanism by which the host immune system discriminates
friends from foes in the interplay with microorganisms, demon-
strating that the IR to spores is closer to the response to the well-
known pathogen C. albicans.
Whole-genome transcriptional analysis of moDCs stimulated
with S. cerevisiae cells or spores and C. albicans hyphae confirms
the presence of a peculiar transcriptional program governing the
recognition of fungi, be they pathogenic or commensal. The DC
transcriptional response to pathogenic fungi has been previously
addressed, in part. The transcriptional report of DCs stimulated
with a C. albicans strain defective in filamentous development in
experimental conditions largely superimposable on those used in
our paper was offered by Huang et al. (43). The overall response,
taking into account the different technology used in that experi-
ment, is more closely related to S. cerevisiae cells than to C. albi-
cans hyphae. In fact, some of the genes (e.g., CD83, IL12A, TNFA,
IL6, IL1B, and more) found to be differentially regulated by Huang
et al. were also found to be differentially regulated in a similar
manner in our experiment, using DCs stimulated with S. cerevisiae
cells.
Our results demonstrate the usefulness of S. cerevisiae as a tool to
learn the rules of cohabitation between yeast and its host. The re-
lationship between humans and S. cerevisiae is so strong that some
strains of this species are often referred to as domesticated organ-
isms (44). Although pathogenic fungi have been thoroughly in-
vestigated, to the best of our knowledge this is the first study
demonstrating that different forms of the same nonpathogenic
FIGURE 7. MR and DC-SIGN in-
volvement in S. cerevisiae recognition. A,
Untreated DCs or DCs pre-exposed to
receptor agonists, laminarin, mannan,
and chitin, were incubated with yeasts
and spores for 6 h. TNF-a production was
inhibited by receptor agonist treatment
only in yeast-stimulated DCs. B, DC-
SIGN specifically binds to both S. cer-
evisiae cells and spores. PKH206-labeled
transfectant (CHO) cells stably express-
ing DC-SIGN were exposed to FITC-
labeled yeast (black bars) or spores
(white bars). mAbs AZN-D1/D2/D3 and
L19 were used to block DC-SIGN and
b2-integrin, respectively. Addition of
EGTA showed that DC-SIGN–mediated
binding is Ca2+ dependent. C, D, Imma-
ture DCs bind S. cerevisiae through C-
type lectins. CD45-APC–labeled DCs
were incubated with FITC-labeled yeast
(black bars) or spores (white bars) in the
presence or absence of anti–DC-SIGN
mAb, a mixture of anti–DC-SIGN Abs,
anti-MR mAb, EDTA, and anti–b2-
integrin Ab as control or SC-mannan,
CA-mannan, b-glucan, or mannose. Basal
binding (TSA) is set as 100%. E, Labeling
of MR (in red) and DC-SIGN (in green)
shows considerable colocalization with
yeast cells (asterisk) as indicated by the
white arrow (first panel). Spores are in-
ternalized by DC-SIGN–containing vesi-
cle only as indicated by the white arrow
(second panel). All data are presented as
mean 6 SD (n = 3). Statistical compar-
isons between samples are represented as
horizontal bars. pp , 0.05; ppp , 0.01.
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microorganism stimulate profoundly different IRs and that skewing
in the use of PRRs dictated by differences in cell wall composition
is a requirement for pathogenicity. Our results demonstrate that,
despite the lack of IL-12p70 production by DCs, spores, a peculiar
form of S. cerevisiae, induce a Th1/Th17 polarization of CD4+
T cells. In contrast, the activation of suppressive mechanisms, such
as the increased expression of the IDO gene in DCs and the in-
duction of a CD4+ FOXP3+ regulatory T cell population, was ob-
served upon yeast cell stimulation. Furthermore, in contrast to what
happened with yeast cells, spores seem to interact with DC with
a reduced activation of NADPH oxidase, inducing a poor fungicidal
activity of these cells, as previously reported for C. albicans (38).
Further investigation into the nature of this possible oxidative
damage escape mechanism will be carried out in follow-up studies.
Thus, far from being inactive microbes, yeast cells activate a de-
fined pathway of IRs in moDCs, balancing each other to avoid
potentially harmful inflammatory processes.
Similar to what was reported for C. albicans (9), we report that
interaction between S. cerevisiae yeast and DCs is mediated by
mannan, rather than other fungal cell wall components. Although
recognition of mannan and mannose by DC-SIGN and MR plays
an important role in binding and phagocytosis of S. cerevisiae
cells by human DCs, DC-SIGN alone seems to have the major role
in spore recognition. Our data suggest that the outermost layer of
dityrosine present on the spore wall could hide important carbo-
hydrates from DCs, influencing immune detection by eluding
important PAMPs.
Our findings indicate that SC-mannan could favor a specific in-
dividual recognition pathway through mannan-recognizing recep-
tors, such asMR,DC-SIGN, or TLR4, that lead to different cytokine
release and the polarization of a Th1 response. By contrast, the
absence of exposed mannan contributes to Th17 induction by the
spores.
In fact, S. cerevisiae och1 mutant, defective in the N-man-
nosylation process, induces a Th1/Th17 response comparable to
that induced by spores, highlighting the importance of the mannan
layer in influencing the T cell response to better cope with in-
vading pathogens.
The differential recognition of mannan from C. albicans and S.
cerevisiae is most likely related to the different branching of these
structures. CA-mannan induces potent Th17 responses (10),
whereas SC-mannan does not, suggesting that MR could be dif-
ferently engaged by C. albicans and S. cerevisiae. The relative
contribution of DC-SIGN in Th17 priming is under investigation.
Although S. cerevisiae cannot qualify as a human saprophyte or
commensal, throughout human civilization the consumption of
bread and fermented beverages has exposed our immune system to
this yeast on a daily basis, without harmful effect—on the contrary,
with potential beneficial effects. The evidence that S. cerevisiae
spores do not induce IL-12p70 and are resistant to phagocytosis
suggests that sporulation may be a mechanism for circumventing
adaptive IRs and tolerance. Both Th1 (33) and Th17 (45–47) cells
have been proposed to mediate protection against pathogenic fungi
and in particular against C. albicans. C. albicans can switch from
being an intracellular form, the yeast, that can be efficiently de-
stroyed by macrophages with the help of Th1 cells, to being an
extracellular form, the hyphae, that is better controlled by neu-
trophils (48) recruited by Th17 cells. Th1 cells express CXCR3 and
migrate toward IFN-dependent chemokines, such as CXCL10 and
CXCL11, which are preferentially induced in response to the yeast.
In turn, Th17 cells express CCR6 and are recruited in response to
CCL20, which is preferentially expressed in the presence of hyphae.
FIGURE 8. Role of exposed mannan in defining IRs
to S. cerevisiae. A, SC-mannan inhibits Th17 response
induced by spores. DCs were exposed (white bars) or
not (black bars) to an excess of SC-mannan (100 mM)
for 2 h and stimulated with spores (4:1, stimuli/DC
ratio) for 8 h. Thus, the coculture with CD4+ T cells
was performed. IL-12p70, IFN-g, and IL-17 were
measured. B, Absence of mannan induces Th17 po-
larization. DCs were exposed to cells of different
S. cerevisiae strains (SK1, BY4741 wild type, BY4741
och1 mutant), to C. albicans, and to SK1 spores (4:1,
stimuli/DC ratio) for 12 h, and their capacity to prime
Th17 or Th1 polarization of T cells was assessed by
IL-12, IL-17, and IFN-g measurement by ELISA. C,
DCs were exposed to S. cerevisiae cells and spores and
to C. albicans (light gray bars). mAbs were used to
block MR (black bars) or DC-SIGN (white bars), or
exposure to SC-mannan (dark gray bars) was used.
After 12 h, IL-12-p70 was measured, and after 5 d of
coculture, IL-17 was assessed on T cell supernatants.
All data are presented as mean6 SD (n = 3). Statistical
comparisons between samples are represented as hor-
izontal bars. pp , 0.05; ppp , 0.01.
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This observation is consistent with the differential chemokine pro-
file we observed in cells challenged with the S. cerevisiae yeast or
C. albicans hyphae. Accordingly, the pattern of chemokine ex-
pression induced by the spore is similar to that induced by the hy-
phae. Thismight represent amechanism to escape theTh1 responses
mediated by the CXCR3–CXCL10 axis and to favor a Th17 re-
sponse, which might favor spore expulsion. Our finding may have
relevance for autoimmune diseases, such as inflammatory bowel
disease (IBD), in which S. cerevisiae spores could play a role in the
inflammation process mediated by a mixed Th1/Th17 response.
Interestingly, anti-S. cerevisiae Abs can be detected in a subset of
patients with Crohn’s disease and are considered markers of active
disease (49). The capacity of S. cerevisiae spores to promote IL-17
release could contribute to the pathogenesis of this disease; there-
fore, sporulation could be a potential target for therapy.
It has been recently shown that survival of S. cerevisiae spores in
Drosophila melanoglaster gut is increased, compared with yeast
cells (50), and that spores are thus more resistant to innate mecha-
nisms of protection.
In vivo preliminary results (C. De Filippo, L. Rizzetto, and
D. Cavalieri, unpublished observations) suggested that spores have
a stronger capacity to survive through the gut. The different
pathway of IR activated by spores compared with yeast cells in
DCs could be involved in such increased survival. Further inves-
tigations are needed to clarify this issue.
Reports of spores in mammalian intestine are rare, probably
owing to the habit of culturing fecal samples rather than observing
them by microscopy. Our findings open new avenues for further
investigation into the in vivo nature of the IR in animal models and
in patients with IBD in future studies.
Tolerance requires the ability of the microbe to circumvent
inflammatory signals evolved in response to potentially pathogenic
microorganisms. We demonstrate that differential recognition of
specific mannan structures is one of the major regulators of dis-
criminating between harmful and harmless fungi, emphasizing the
importance of deeper insight into the specific contribution of each
receptor in fungal recognition.
The higher capacity of SC-mannan to induce a IL-12/Th1
protective response is likely to play a major role in the non-
pathogenicity of S. cerevisiae and its commensalism in humans.
Our findings are ecologically important, as insects and mamma-
lians that feed on fruits and fermented beverages are continuously
contaminated with yeasts that can potentially colonize the gut.
Sporulation may have evolved in yeast to allow host clearance
while surviving the IR. This trait may be advantageous and may
explain the maintenance of the ability to sporulate, as indicated by
the high sporulation rates of many of the naturally existing strains
(51). The yeast ecological cycle could therefore possibly include
mammals as hosts and vectors.
Our results underline the importance of differences in cell wall
structure that occur during the life stages of S. cerevisiae in con-
veying anti-inflammatory signals. Extending our studies to differ-
ent forms of clinical isolates of S. cerevisiaewill be crucial to fully
understand the rules of proper recognition of fungi and might lead
to development of new drugs to treat fungal infections or IBD.
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